• HOME
  • RESEARCH
  • PEOPLE
    • Matthew S. Davids
    • Current Lab Members >
      • Christine Ryan, MD
      • Stephen Chong, PhD
      • Fen Zhu, PhD
      • Jing Wang, PhD
      • Mary Collins, BS
      • Jeremy Zhang, BS
      • Ritu Somayaji, BS
    • Alumni >
      • Liam Hackett, AB
      • Johannes Hildebrand, MSc
      • Charles Herbaux, MD
      • Rebecca Valentin, MD
      • Timothy Lehmberg, B.A.
      • Stephanie Grabow, PhD
      • Simon Husby, MD
  • PUBLICATIONS
  • JOBS
  • SUPPORT US
  • NEWS
    • Awards and Recognition
  • CONTACT
Davids Lab - Translational CLL Research

The Davids Lab
TRANSLATIONAL CLL RESEARCH

Picture

Stephen Chong, PhD

Postdoctoral Fellow
 
PhD, 2017, National University of Singapore, Singapore
 
Stephen joined the Davids Lab in 2019 after a 2-year postdoctoral training with Professor Shazib Pervaiz in a Redox and Cancer Biology Lab at National University of Singapore.
 
He is working on elucidating the effects of post-translational modifications of the Bcl-2 family members on BH3 mimetics as well as identifying potential drugs to target these modifications as a goal to sensitize CLL cells to BH3 mimetics. 
 
He brings to the Davids Lab his previous laboratory experience of molecular and fundamental work ranging from protein, mRNA and in vitro cellular work in hematological cancers.
 
In his spare time, he likes to gym, run and play video games. He hopes to explore Boston, Massachusetts and the rest of the country with his wife.

StephenJ_Chong@DFCI.HARVARD.EDU

 HOME | RESEARCH | PEOPLE | PUBLICATIONS | JOBS | SUPPORT US | NEWS | CONTACT 

©2016 Translational CLL Research at Dana-Farber Cancer Institute